This growing interest among researchers in the field of MTH1 inhibition is supported by prior studies demonstrating that TH588 effectively inhibits the growth of malignant melanomas in murine models, as well as various other cancers, including SW480 colorectal tumors, glioblastomas, and MCF7 breast cancer tumors [13]. Here, NUDT1 is linked to breast carcinoma.